Clinical Trial Update: Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial updating the combo of ipilimumab and nivolumab with SBRT for locally advanced hepatocellular carcinoma; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Hawaii | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: NOT_YET_RECRUITING